In this systematic review and meta-analysis of 3 Phase 2 RCTs and 454 patients, we compared Once-Weekly Insulin Icodec with Once-Daily Insulin Glargine U100 in patients with Diabetes Mellitus Type 2. The gene discussed is INS; the disease is diabetes mellitus.